Funded Tech Companies
BioAtla
Wondering who backed BioAtla? Pfizer Venture Investments, HBM Healthcare Investments and Farallon Capital Management joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
BioAtla
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11085 Torreyana Rd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
BioAtla (Nasdaq: BCAB) is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/15/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Short
Chief Financial Officer
Richard Waldron
Chief Scientific Officer
Gerhard Frey
Co-Founder
Carolyn Short
Vice President
William Boyle
Vice President
Philippe Martin
Vice President
Monica Sullivan
VP - Bus. Development
Michael Melnick
VP - Human Resources
Susie Melody
VP - R & D
Cathy Chang
Company Investors
- Pfizer Venture Investments
- HBM Healthcare Investments
- Farallon Capital Management
- Soleus Capital
- Boxer Capital
- Pappas Ventures
- Cormorant Asset Management
- Janus Henderson Investors
- Global BIO Impact Fund (John Evey)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs